Mechanisms of Pseudomonas Resistance to Membrane Permeabilization by SP-A

假单胞菌对 SP-A 膜透化的抗性机制

基本信息

  • 批准号:
    8237000
  • 负责人:
  • 金额:
    $ 38.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Traditionally, the pulmonary surfactant protein-A (SP-A) is thought to opsonize and enhance the clearance of microbial pathogens. Recently, we have reported that SP-A also directly kills Pseudomonas aeruginosa (PA) in a macrophage-independent manner, by increasing the permeability of bacterial membranes. However, the mechanism by which SP-A disrupts PA cell membranes and its relative importance in lung defense are poorly defined. In addition, how microbes protect themselves against SP-A is unknown. Especially, we have shown that wild-type PA strain PA01 is resistant to membrane permeabilization by SP-A. Our long-term goal is to understand the antimicrobial mechanisms of SP-A, and to reveal how bacteria confer resistance/susceptibility to SP-A. The overall hypothesis to be tested is that PA pathways including flagellum, salicylate and pyochelin, and phosphoenol-pyruvate phosphotransferase, are important to resist membrane permeabilization by SP-A. Our hypothesis is supported by our published and preliminary data which show that PA mutant strains deficient in flagellum (flgE), deficient in salicylate and pyochelin biosynthesis (pchA), and defective in producing phosphoenol-pyruvate phosphotransferase (ptsP), are preferentially cleared in the SP-A+/+ mouse lungs, but survived in the SP-A-/- mouse lungs. Most strikingly, the flgE, pchA and ptsP mutant bacteria show significant increase in susceptibility to SP-A mediated membrane permeabilization, but not opsonization. We propose three aims to examine the mechanisms by which flagellum, PchA and PtsP pathways maintain LPS and cell membrane integrity, and regulate the bacterial processes that inactivate SP-A, to confer resistance to killing by SP-A-mediated membrane permeabilization and to killing by SP-A and antimicrobial peptides and proteins (AMPPs) whose functions that are either dependent or aided by SP-A. Aim 1 will determine the "offensive" strategies orchestrated by PA's flagellum, PchA and PtsP to confer resistance to SP-A-mediated membrane permeabilization. These offensive measures to be tested include the ability of PA to secrete proteases that degrade SP-A, and to secrete salicylate that strips Ca2+ associated with SP-A, which is required for the activity of SP-A. Aim 2 will determine the "defensive" strategies orchestrated by PA's flagellum, salicylate/pyochelin and phosphoenol-pyruvate phosphotransferase to confer resistance to SP-A-mediated membrane permeabilization. The defensive measures to be determined include increased LPS biosynthesis and modification, and chemotaxis evasion. Aim 3 will examine the hypothesis that during the initial interactions, SP-A preemptively "paralyzes" PA, allowing other AMPPs to act synergistically or additively to kill the bacteria. We will use "checker board" assays to determine the roles of flagellum, PchA and PtsP pathways against individual, synergistic and additive killing by individual AMPP alone, different combinations of AMMPs, and AMMPs with SP-A. Completion of the proposed aims will enhance our understanding of the antimicrobial mechanisms of the SP-A and lead to new treatment strategies for pneumonias. PUBLIC HEALTH RELEVANCE: Pseudomonas aeruginosa is one of the most common causes of nosocomial infections in humans, lung infections in cystic fibrosis patients, and a primary cause of death and sepsis in immuno-compromised individuals. The continuous emergence of antibiotic resistant P. aeruginosa, which can lead to denial for lung transplant, infection and death, emphasize the urgent need to explore alternative strategies to manage P. aeruginosa infections. Enhance understanding of the antimicrobial mechanisms of the Surfactant Protein A, and the mechanisms by which P. aeruginosa confers resistance/susceptibility to Surfactant Protein A may lead to new treatment strategies for life-threatening pneumonias.
描述(由申请人提供):传统上,认为肺表面活性剂蛋白A(SP-A)被认为可以调整并增强微生物病原体的清除率。最近,我们报告说,SP-A还通过增加细菌膜的渗透性来直接以巨噬细胞独立的方式杀死铜绿假单胞菌(PA)。然而,SP-A破坏PA细胞膜及其在肺防御中的相对重要性的机制的定义很差。此外,微生物如何保护自己免受SP-A的侵害是未知的。特别是,我们已经表明,野生型PA菌株PA01对SP-A的膜透化具有抗性。我们的长期目标是了解SP-A的抗菌机制,并揭示细菌如何赋予SP-A的耐药性/敏感性。要测试的总体假设是PA途径在内,包括鞭毛,水杨酸酯和毕胆素以及磷酸烯醇 - 丙酮酸磷酸磷酸转移酶,对于通过SP-A抵抗膜通透性很重要。 Our hypothesis is supported by our published and preliminary data which show that PA mutant strains deficient in flagellum (flgE), deficient in salicylate and pyochelin biosynthesis (pchA), and defective in producing phosphoenol-pyruvate phosphotransferase (ptsP), are preferentially cleared in the SP-A+/+ mouse lungs, but survived in the SP-A - / - 小鼠肺。最引人注目的是,FLGE,PCHA和PTSP突变细菌显示出SP-A介导的膜通透性的敏感性显着增加,但没有调理。 We propose three aims to examine the mechanisms by which flagellum, PchA and PtsP pathways maintain LPS and cell membrane integrity, and regulate the bacterial processes that inactivate SP-A, to confer resistance to killing by SP-A-mediated membrane permeabilization and to killing by SP-A and antimicrobial peptides and proteins (AMPPs) whose functions that are either dependent or aided by sp-a。 AIM 1将确定PA的Flagellum,PCHA和PTSP精心策划的“进攻”策略,以赋予SP-A介导的膜通透性的抵抗力。这些要测试的进攻措施包括PA分泌降解SP-A的蛋白酶的能力,并分泌与SP-A相关的ca2+的水杨酸盐,这是SP-A活性所必需的。 AIM 2将确定PA的鞭毛,水杨酸酯/毕胆素和磷酸烯醇 - 丙酮酸磷酸转移酶策划的“防御”策略,以赋予SP-A介导的膜透气化的耐药性。要确定的防御措施包括增加的LPS生物合成和修饰以及趋化性逃避。 AIM 3将研究以下假设:在最初的相互作用中,SP-A先发制于“瘫痪” PA,允许其他AMPP协同或附加的作用以杀死细菌。我们将使用“ Checker板”测定法来确定单独的AMPP,不同的AMPS的不同组合和SP-A的AMMP,以确定鞭毛,PCHA和PTSP途径的作用。拟议的目标的完成将增强我们对SP-A的抗菌机制的理解,并导致针对肺炎的新治疗策略。公共卫生相关性:铜绿假单胞菌是人类中医院感染,囊性纤维化患者的肺部感染以及免疫增强个体中死亡和败血症的最常见原因之一。抗生素抗生素铜绿假单胞菌的连续出现,这可能导致肺部移植,感染和死亡的拒绝,这强调了迫切需要探索管理铜绿假单胞菌感染的替代策略。增强对表面活性剂蛋白A的抗菌机制的了解,以及铜绿假单胞菌赋予表面活性剂蛋白A的耐药性/易感性的机制,可能会导致危及生命的肺炎的新治疗策略。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Competence-independent activity of pneumococcal EndA [corrected] mediates degradation of extracellular dna and nets and is important for virulence.
  • DOI:
    10.1371/journal.pone.0070363
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Zhu L;Kuang Z;Wilson BA;Lau GW
  • 通讯作者:
    Lau GW
Surfactant phospholipids act as molecular switches for premature induction of quorum sensing-dependent virulence in Pseudomonas aeruginosa.
  • DOI:
    10.1080/21505594.2020.1809327
  • 发表时间:
    2020-12
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Kuang Z;Bennett RC;Lin J;Hao Y;Zhu L;Akinbi HT;Lau GW
  • 通讯作者:
    Lau GW
Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.
IV 型菌毛糖基化介导铜绿假单胞菌对肺表面活性蛋白 A 调理活性的抗性。
  • DOI:
    10.1128/iai.02874-14
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Tan,RommelM;Kuang,Zhizhou;Hao,Yonghua;Lee,Francis;Lee,Timothy;Lee,RyanJ;Lau,GeeW
  • 通讯作者:
    Lau,GeeW
Pseudomonas aeruginosa pyocyanin modulates mucin glycosylation with sialyl-Lewis(x) to increase binding to airway epithelial cells.
  • DOI:
    10.1038/mi.2015.119
  • 发表时间:
    2016-07
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Jeffries JL;Jia J;Choi W;Choe S;Miao J;Xu Y;Powell R;Lin J;Kuang Z;Gaskins HR;Lau GW
  • 通讯作者:
    Lau GW
Correction: Competence-Independent Activity of Pneumococcal Enda Mediates Degradation of Extracellular DNA and Nets and Is Important for Virulence.
更正:肺炎球菌 Enda 的能力独立活性介导细胞外 DNA 和网络的降解,并且对毒力很重要。
  • DOI:
    10.1371/annotation/75f51a45-a2de-4893-94cf-0045056a4d7c
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Zhu,Luchang;Kuang,Zhizhou;Wilson,BrendaA;Lau,GeeW
  • 通讯作者:
    Lau,GeeW
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gee W Lau其他文献

Gee W Lau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gee W Lau', 18)}}的其他基金

Mechanistic triggers of excessive mucus during lung infections by bacterial volatile organic compounds
细菌挥发性有机化合物肺部感染期间粘液过多的机制触发因素
  • 批准号:
    10666271
  • 财政年份:
    2023
  • 资助金额:
    $ 38.6万
  • 项目类别:
Controlling bactermic pneumococcal pneumonia with synthetic dominant-negative competence peptides
用合成的显性失活肽控制细菌性肺炎球菌肺炎
  • 批准号:
    10162655
  • 财政年份:
    2019
  • 资助金额:
    $ 38.6万
  • 项目类别:
Controlling bactermic pneumococcal pneumonia with synthetic dominant-negative competence peptides
用合成的显性失活肽控制细菌性肺炎球菌肺炎
  • 批准号:
    9893021
  • 财政年份:
    2019
  • 资助金额:
    $ 38.6万
  • 项目类别:
Controlling bactermic pneumococcal pneumonia with synthetic dominant-negative competence peptides
用合成的显性失活肽控制细菌性肺炎球菌肺炎
  • 批准号:
    10373089
  • 财政年份:
    2019
  • 资助金额:
    $ 38.6万
  • 项目类别:
Mechanisms of Pseudomonas Resistance to Membrane Permeabilization by SP-A
假单胞菌对 SP-A 膜透化的抗性机制
  • 批准号:
    7649170
  • 财政年份:
    2009
  • 资助金额:
    $ 38.6万
  • 项目类别:
Mechanisms of Pseudomonas Resistance to Membrane Permeabilization by SP-A
假单胞菌对 SP-A 膜透化的抗性机制
  • 批准号:
    8049617
  • 财政年份:
    2009
  • 资助金额:
    $ 38.6万
  • 项目类别:
Mechanisms of Pseudomonas Resistance to Membrane Permeabilization by SP-A
假单胞菌对 SP-A 膜透化的抗性机制
  • 批准号:
    7790727
  • 财政年份:
    2009
  • 资助金额:
    $ 38.6万
  • 项目类别:

相似国自然基金

转移相关中性粒细胞(TMAN)代谢重塑促三阴性乳腺癌嗜肺转移的作用与分子机制
  • 批准号:
    82372823
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
AeAPX1交叉调控毛花猕猴桃果实AsA代谢与耐热性的分子机制
  • 批准号:
    32302490
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
APOE调控小胶质细胞脂代谢模式在ASD认知和社交损伤中的作用及机制研究
  • 批准号:
    82373597
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
DJ-1通过影响UCP1稳定性调控机体代谢稳态的机制研究
  • 批准号:
    32371194
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
桑叶多糖与肠道菌群互作产物通过影响肝miRNA调控脂代谢的作用机制研究
  • 批准号:
    32372245
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 38.6万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 38.6万
  • 项目类别:
Elucidating the genotypic determinants and phenotypic effects of polymyxin resistance in Klebsiella pneumoniae utilizing CRISPR-Cas9
利用 CRISPR-Cas9 阐明肺炎克雷伯菌多粘菌素耐药性的基因型决定因素和表型效应
  • 批准号:
    10431975
  • 财政年份:
    2020
  • 资助金额:
    $ 38.6万
  • 项目类别:
Elucidating the genotypic determinants and phenotypic effects of polymyxin resistance in Klebsiella pneumoniae utilizing CRISPR-Cas9
利用 CRISPR-Cas9 阐明肺炎克雷伯菌多粘菌素耐药性的基因型决定因素和表型效应
  • 批准号:
    10055453
  • 财政年份:
    2020
  • 资助金额:
    $ 38.6万
  • 项目类别:
Elucidating the genotypic determinants and phenotypic effects of polymyxin resistance in Klebsiella pneumoniae utilizing CRISPR-Cas9
利用 CRISPR-Cas9 阐明肺炎克雷伯菌多粘菌素耐药性的基因型决定因素和表型效应
  • 批准号:
    10203821
  • 财政年份:
    2020
  • 资助金额:
    $ 38.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了